Gazette.govt.nzPursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:
Schedule
| Product: | Gutron |
| Active Ingredient: | Midodrine hydrochloride 2.5mg |
| Dosage Form: | Tablet |
| New Zealand Sponsor: | Douglas Pharmaceuticals Limited |
| Manufacturer: | Takeda GmbH, Oranienburg, Germany |
| Note: This renewed consent is valid for two years from 30 April 2020. | |
| Product: | Gutron |
| Active Ingredient: | Midodrine hydrochloride 5mg |
| Dosage Form: | Tablet |
| New Zealand Sponsor: | Douglas Pharmaceuticals Limited |
| Manufacturer: | Takeda GmbH, Oranienburg, Germany |
| Note: This renewed consent is valid for two years from 30 April 2020. | |
Dated this 14th day of April 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).